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Abstract Epidemiological studiesindicate a lowerprevalence of asthma in EasternthanWestern Europe.This studyof
the prevalence of asthma, chronic bronchitis, and respiratory symptoms was performed in three di¡erent regions of
Estonia, a state incorporated in the Soviet Union until 1991. A postal questionnaire was sent to a random sample of
24307 ofthe population aged15^64 years.Theresponse ratewas 77?6%.The prevalence of physician-diagnosed asthma
was 2?0% orconsiderably lower thanin Northern andWestern European countries.The prevalence of wheezinglast12
months, 21?7%, recurrent wheeze,13?3%, and attacks of shortness of breath,12?5%, were similar or even higher com-
paredwithprevalencerates foundintheNordiccountries.Theprevalence ofphysician-diagnosedchronicbronchitiswas
10?7%, andwas higher among womenthan inmen, althoughthe proportion of current smokers amongmen, 57%, was
considerably greater than inwomen, 28%. A possible explanation to the high prevalence of respiratory symptoms also
among non-smoking women may be exposure to environmental tobacco smoke in small, crowded Estonian homes.
Diagnostic criteria based on the Soviet-time de¢nitions is discussed as a possible explanation to the low prevalence of
physician-diagnosed asthma and high prevalence of chronic bronchitis in Estonia compared with other Northern Eur-
opean countries.c 2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1188, available online at http://www.idealibrary.comon
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Recent studies on asthma have shown that the preva-
lence in several West European countries varies from 6
to 9% (1^5). In Eastern Europe a lower prevalence of
asthma has been reported (l^5).The prevalence of asth-
ma in Estonia in1990 in the cityof Tallinn and the island of
Saaremaa was found to be only 0?5% and 0?4%, respec-
tively (6). In 1994 the prevalence of asthma inTartu, the
second biggest city of Estonia, was estimated at 2?0%,
compared with 3?3% in a parallel study in Uppsala,
Sweden (7).
The prevalence of chronic bronchitis in Estonia in1977
was reported to be 7?1% inTallinn and 8?0% in Saaremaa
among subjects aged 18 years or more (8). Even higherReceived 5 December 2000 and accepted in revised form16 July 2001.
Correspondence shouldbe addressed to:MariMeren,MD,Department
of Pulmonology, Institute of Experimental andClinicalMedicine,42Hiiu
str,11619 Tallinn, Estonia.Fax: +372 6 099130; E-mail: meren@online.eeprevalence rates of chronic bronchitis have been re-
ported from Finland (9,10), while the prevalence of
chronic bronchitis in Sweden in1970s and1980s was esti-
mated at around 4% (11^13).
The aim of this study was to estimate the pre-
valence of asthma, chronic bronchitis and respiratory
symptoms among adults in Estonia by a postal question-
naire survey. Three areas of the country were selected
for the survey. In order to obtain su⁄cient data for
calculation of risks of the diseases and to have a reliable
starting point for longitudinal studies, 24307 adults
were invited toparticipate. A second aimwas toevaluate
if di¡erent diagnostic labelling compared to western
countries could have had an in£uence on reported pre-
valence rates.The current study was the ¢rst large epi-
demiological investigation of obstructive airways
diseases in Estonia, and Eastern Europe as well, after
the restitution of the independence of the Baltic
countries.
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Study area
Estonia is themost northern country of the three Baltic
States.The country is situated on the north-west part of
the East European PlainTerritory.The area of Estonia is
45227km2; it had l 446 000 inhabitants in1996.The pro-
portion of the urban population is around 70%. Major
ethnic groups are Estonians (65%) and Russians (28%).
The study covered the capital of the country, Tallinn, an
agricultural island in the Baltic Sea, Saaremaa, and a
heavily industrialized town located at theRussianborder,
Narva (Fig.1,Table1).The data about atmospheric air pol-
lutionhasbeen issuedby the Estonian EnvironmentalRe-
search Centre. The data was measured continuously in
permanent locations within the study areas and annual
means based onmonthlymeans have been given.
Study population
The study samplewas randomly selected from the Esto-
nian State Computing Center based on data of July1995.
The sample consisted in total of 24307 subjects aged
15^64 years, of which 12494 were living inTallinn, 6013
in Narva, and 5800 in Saaremaa. In order to achieve
representative samples of the population allowing for
comparison of results between the areas, the samples in
each area were strati¢ed according to age and gender.
Randomization was performed within strata, and each
age group (15^24 years; 25^34 years; 35^44 years; 55^
64 years) included similar numbers of men and women,
approximately 1200 in Tallinn, and respectively 600 in
Narva and Saaremaa.FIG. 1. Map of Estonia.Methods
The study was a postal survey with similar design as in
parallel studies (14) in progress in Finland and Sweden,
the FinEsS studies. As the study aimed to screen for asth-
ma, chronic bronchitis and COPD, a validated question-
naire covering these conditions, the Obstructive Lung
Disease in Northern Sweden Studies (OLIN) question-
naire (13,15), which is a commonly used questionnaire in
theNordic countries, was chosen.The questionnairehad
been developed from a Swedish variant (11) of the British
MRCQuestionnaire (16),with in£uences from theUSTuc-
son and National Heart, Lung and Blood Institute
(NHLBI) questionnaires (17), and the AmericanThoracic
Society (ATS) questionnaire (18) regarding questions
about asthma. In the current study questions about
wheezing from the International Union AgainstTubercu-
losis and Lung Disease (IUATLD) questionnaire (19,20)
were added, questions that had been used in the Eur-
opean Community Respiratory Health Survey (ECRHS)
(I).The English version of the expanded OLIN question-
nairewas translated to Estonian and additional questions
about socio-demographic data were added. The ques-
tionnaire was further translated from English into
Russian, and both the Estonian and Russian versions
were translated back into English.The questionnaire in-
cluded 28 questions about respiratory symptoms and
diseases, diagnoses con¢rmed by physicians, symptoms
in special circumstances or due to speci¢c exposures, fa-
mily history, use of medicines, smoking habits and pro-
fession. The questions about symptoms and diagnoses
required either ‘yes’or ‘no/don’t know’answers. Subjects
who had stopped smokingmore than12 months prior to
the study were classi¢ed as ex-smokers. Those who
TABLE 1. Characteristics of the study areas
Tallinn Narva Saaremaa
Population1January1994 442679 79 094 40 822
Territory inkm2 158 85 2992
Population densityinkm72 2800 930 14
Type of settlement Urban Urban Rural/urban 60/40%
Type of industry Industrial Power plants Farming
Commercial Chemicalplants Fishing
Administrative Textile factories Tourism
Ethnic composition Estonians 50% Estonians 6% Estonians 98%
Non-Estonians 50% Non-Estonians 94% Non-Estonians 2%
Average temperature (8C)
February 76 76 73
July 16 17 16
Air pollution (1996) Measured inthree di¡erentplaces Measured inthree
di¡erentplaces
Measured in coast
SO2 (mgm
2, annualmeans) 7?5 7?7 2?5
Rates 1^20 5^10 0?4^9?8
Standard deviation 4?3 1?4 2?9
NO2 (mgm
2, annualmeans) 21?7 16?2 3?5
Rates 3^68 8^31 3^7
Standard deviation 15?3 4?3 1?9
956 RESPIRATORYMEDICINEcurrently smoked or had stopped smoking within the
last 12 months prior to the study were classi¢ed as
smokers.
The questionnaires with an accompanying letter and
an enclosed stamped addressed reply envelope were
mailed in November1995.The Estonian versionwas sent
to the subjectswith Estoniannames, and theRussianver-
sion to the subjects with non-Estonian names. In case of
uncertain nationality, questionnaires in both languages
were sent. A reminder and a new questionnaire were
sent to subjects who did not respond within 2 months.
If necessary, the second reminder was sent 2 months
later. All data were collected from November 1995 to
May1996.
The study was approved by the Tallinn Ethics
Committee.
Diagnostic criteria
The diagnoses were based on the answers to questions
or combinations of questions about respiratory symp-
toms and diseases, and these were considered to prevail
when the corresponding questions were answered ‘yes’
as follows:
Longstanding cough: ‘Have you had longstanding cough
during the last years?’
Sputum production: ‘Do you usually have phlegmwhen
coughing, or do you have phlegm on your chest, which is
di⁄cult to bring up?’Chronic productive cough: The criterion for sputum
production ful¢lled, and in addition a ‘yes’ answer to the
question‘Haveyou had such periods onmost days during
at least 3 months at least 2 successive years?’
Any wheeze last 12 months: Have you had wheezing or
whistling in your chest at any time in the last12months?’
Recurrent wheeze: ‘Have you usually wheezing, whis-
tling, or a noisy sound in your chest when breathing?’
Attacks of shortness of breath last 12 months:‘ Have you
had asthma symptoms during the last 12 months (inter-
mittentbreathlessness or attacks of shortness of breath;
the symptomsmay exist simultaneously with or without
cough or wheezing)?’
Self-reported (ever) asthma: ‘Have you nowor have you
had asthma?’
Self-reported (ever) chronic bronchitis: ‘Have you now or
have you had chronic bronchitis or emphysema?’
Physician-diagnosed asthma: ‘Have you been diagnosed
as having asthma by a physician?’
Physician-diagnosed chronic bronchitis: ‘Have you been
diagnosed as having chronic bronchitis or emphysema by
a physician?’
Statisticalmethods
Statistical analyses were performedby using the Statisti-
cal Package for Social Sciences (SPSS) at the Respiratory
Unit at the National Institute for Working Life in
Sweden. Categorical comparisons were performed by
FIG. 2. Prevalence (%) of current smokers by age andgender.
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analysis of variance (ANOVA) was used to test for
trends. Multiple logistic regression analysis was used to
assess the simultaneous in£uences of possible determi-
nants of symptoms or diseases and e¡ects of possible
interaction. The independent variables included age,
gender, a family history of asthma or chronic bronchitis,
smoking habits and area of domicile, which re£ects air
pollution and degree of urbanization as well.
RESULTS
Participation
Of the 24307 randomly selected subjects1728, or 7?1% of
the original study sample, were either dead, had moved
abroad or were living elsewhere having other addresses.
Thus, the remaining 22 579 subjects constituted the
adjusted study cohort.
In total, 19 253 answers were received. Among the
answers, 341 were received from subjects not included
in the sample, for instance other family members or
persons living at the addresses but not included in the
study sample. After exclusion of all incorrect answers,
the remaining17525, or 77?6% of the real study sample,
could be included in the study. The response rate was
88?5% in Saaremaa, 78?4% in Narva and 72?9% inTallinn.
With a few exceptions, no large di¡erences between age
groups were found. The lowest participation rate was
found among men in Tallinn aged 35^44 years, 64?0%,
and the highest among women aged15^24 years in Saar-
emaa, 93?5%.The participation ratewas generally higher
among women, 81?1%, than among men, 73?7%
(P50?001).
Smoking habits
Less than 1% of the responders did not answer to the
questions about smoking habits. The proportion of
smokers was 57?2% in men and 28?1% in women, and si-
milar in the three study areas: 39?1% in Saaremaa, 42?5%
in Narva and 41?3% inTallinn. In all centers the highest
proportion of smokers were found in the age group 25^
34 years. Among men 14?7% were ex-smokers and
among women 7?4%, while 28?0% of men and 64?2% of
women were non-smokers. Smoking habits are shown
in Fig. 2.
Respiratory symptoms
The most common symptom was sputum production,
29?5%, followed by longstanding cough 24?0%. The
prevalence of any wheeze during the last12 months was
21?7%, of recurrent wheeze 13?3% and attacks of short-
ness of breath were reported by 12?5%. The prevalence
of respiratory symptoms increased with age, while nomajor gender di¡erences were found, though the
proportion of smokers among men were considerably
higher than among women. All respiratory symptoms
were most prevalent in Narva. The prevalence rates
were in general lowest in Saaremaa, however, the
prevalence of any wheeze during the last12 months was
lowest inTallinn (Table 2).
Wheezing, attacks of shortness of breath, or severe
cough were reported by 26% when exposed to tobacco
smoke, and to dust, respectively. At least one respira-
tory symptom was reported by 45% of all responders,
and the regional distribution was 51% in Narva, 42% in
Tallinn and 38% in Saaremaa.
Respiratory symptoms and smoking were strongly
correlated (Tables 2^5, Fig. 3). Smokers generally had
twice more respiratory symptoms than non-smokers.
Most symptoms increased signi¢cantly with the num-
bers of cigarettes smoked per day.The e¡ect of smoking
habits on the prevalence of respiratory symptoms was
stronger inwomen than inmen.
Asthma
Theprevalence of physician-diagnosed asthmawas 2?0%.
Of the three areas it was the lowest in Saaremaa, l?6%.
Ever asthma was reported by 2?7%, use of asthma-
medicines by 2?4, and the prevalence rates were similar
in the three areas and among men and women. Both
physician-diagnosed and ever asthma was more common
in theyoungest and the oldest agegroups comparedwith
middle-aged. The prevalence of the symptom combina-
tion attacks of shortness of breath and recurrent wheeze
was 6?6% (Table 3). A family history of asthma was re-
ported by10% of the responders.
Chronic bronchitis
The prevalence of physician-diagnosed and self-reported
(ever) chronic bronchitis was 10?5% and 10?7%, respec-
TABLE 2. Prevalence (%) ofthe respiratory symptomsbyage, sex andgeographic area.Di¡erence (P-value) by sex, age, smokinghabits and area
15^24 years 25^34 years 35^44 years 45^54 years 55^64 years All Di¡erencesby
Men Women Smokinghabits Sex Area Age
Longstandingcough
Tallinn 21?9 21?8 27?6 25?2 26?6 22?3 26?4
Narva 24?0 28?4 28?6 32?1 30?3 27?5 29?5
Saaremaa 18?3 17?6 17?8 21?0 19?8 18?0 19?5
All 21?3 22?0 25?5 25?8 25?9 22?3 25?4 50?0001 50?0001 50?0001 50?0001
Sputumproduction
Tallinn 27?1 28?9 31?2 27?2 31?2 28?9 29?3
Narva 34?8 38?2 35?8 39?6 38?0 37?7 36?8
Saaremaa 21?4 22?7 24?1 25?6 22?4 24?1 22?2
All 27?1 29?1 30?7 29?7 30?8 29?6 29?4 50?0001 0?857 50?0001 0?021
Anywheeze last12 months
Tallinn 19?0 18?7 21?5 21?8 23?8 22?7 19?7
Narva 23?1 22?4 23?9 24?7 24?0 26?4 21?5
Saaremaa 20?5 19?1 21?5 22?7 23?2 23?4 19?3
All 20?4 19?7 22?2 22?7 23?7 23?8 20?0 50?0001 50?0001 0?0003 50?0001
Recurrentwheeze
Tallinn 8?3 10?0 14?3 12?6 14?7 13?5 10?9
Narva 16?9 19?3 21?2 23?2 23?7 23?1 19?1
Saaremaa 7?1 5?8 8?3 11?7 11?3 9?6 7?7
All 9?9 10?8 14?7 14?9 16?2 14?7 12?1 50?0001 50?0001 50?0001 50?0001
Attacks of breathlessness
last12 months
Tallinn 10?1 10?6 13?1 13?4 15?0 12?5 12?5
Narva 10?8 12?7 13?2 17?8 17?6 14?3 14?4
Saaremaa 8?8 9?5 10?6 14?5 12?2 11?0 10?7
All 9?9 10?7 12?5 14?7 15?0 12?5 12?5 50?0001 0?772 50?0001 50?0001
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TABLE 3. Prevalence (%) of asthma and symptomcombinations associatedwith asthmabyage and sex.Di¡erence (P-value) by
age, sex, geographic area and smokinghabits
15^24 25^34 35^44 45^54 55^64 All Di¡erencesby
Men Women Sex Smoking Area Age
Ever asthma 3?0 1?7 2?0 2?9 4?0 2?7 2?7 0?836 0?203 0?293 50?001
Physician diagnosed asthma 2?4 1?3 1?6 2?1 2?9 2?0 2?1 0?218 0?053 0?042 50?001
Use of asthmamedicines 2?2 1?5 1?5 3?3 3?5 2?1 2?6 50?001 0?534 0?680 50?001
Wheezinglast12 monthswith
breathlessnesswithoutcold
(triad) 3?1 3?0 4?5 5?5 5?6 4?6 4?1 0?004 50?001 0?166 50?001
Attacks of breathlessness
recurrentwheeze 4?3 4?7 6?9 8?3 9?2 7?2 6?1 50?001 50?00 I 50?001 50?001
Attacks of shortness of breath
anywheeze last12 months 6?8 7?6 9?3 11?2 11?6 9?7 8?9 50?001 50?001 0?01 50?001
Ever asthma and triad 5?3 4?2 5?8 6?6 7?8 6?3 5?6 50?001 50?001 0?329 50?001
TABLE 4. Prevalencerates of self-reportedandphysiciandiagnosedchronicbronchitis andchronicproductive coughby smok-
inghabits and sex
Non-
smokers
Ex-
smokers
Smokers
5 5 cigarettes
day71
Smokers
5^14 cigarettes
day71
Smokers
415 cigarettes71
All
Men Women
Self-reported
chronic bronchitis
Tallinn 9?5 11?7 9?3 10?5 13?8 9?3 11?4
Narva 14?3 10?8 13?6 16?1 17?5 12?5 16?5
Saaremaa 6?7 7?4 7?7 8?8 7?1 7?1 7?5
All 10?0 10?2 10?1 11?5 13?1 9?5 11?6
Physician-diagnosed
chronic bronchitis
Tallinn 9?3 10?8 9?2 10?8 14?3 9?6 11?0
Narva 15?3 12?7 13?4 16?8 16?2 12?6 17?5
Saaremaa 5?8 6?0 6?7 8?2 6?4 6?1 6?7
All 9?8 9?6 9?7 11?6 12?8 9?3 11?5
Chronic
productive cough
Tallinn 6?0 5?8 7?9 10?2 18?0 9?7 7?6
Narva 9?8 10?2 12?7 18?8 23?1 15?1 12?4
Saaremaa 3?2 3?2 3?2 8?5 10?9 6?6 3?8
All 6?2 5?7 8?0 11?9 17?6 10?1 7?8
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was reported by15?3% in Narva,10?4% inTallinn and by
6?4% in Saaremaa. Both physician-diagnosed and
self-reported chronic bronchitis were slightly, however
signi¢cantly, more common among women, increased
with age andwere related to smoking.The prevalence of
chronic productive cough increased considerably with
increasing age, was strongly correlated to smoking, and
in contrast to physician-diagnosed chronic bronchitis theprevalence of chronic productive cough was more com-
mon among men. A family history of chronic bronchitis
was reported by13%.
Multivariate relationships
Risk factors for the symptoms chronic productive cough,
recurrent wheeze, attacks of shortness of breath, and
TABLE 5. Risk factors for symptoms chronic productive cough, recurrent wheeze, attacks of shortness of breath, and physician-diagnosed asthma by multiple logistic regression
analysis.Risks in odds ratios (OR) with 95% con¢dence intervals (95% CI)
Independent variables Dependent variables
Variables Categories Chronic productive
cough
Recurrent
wheeze
Attacks of breathlessness
last12 months
Physician-diagnosed asthma
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age (years) 15^24 1 1 1 1
25^34 1?28* (1?04^1?57) 0?91 (0?77^1?08) 0?97 (0?83^1?14) 0?56** (0?33^0?94)
35^44 1?67*** (1?37^2?03) 1?28** (1?09^1?51) 1?14 (0?96^1?38) 0?61** (0?37^0?97)
45^54 2?03*** (1?65^2?49) 1?49*** (1?26^1?78) 1?49*** (1?27^1?78) 0?84 (0?71^1?11)
55^64 2?64*** (2?16^3?23) 2?08*** (1?85^2?41) 1?74*** (1?42^2?23) 1?12 (0?90^1?36)
Sex Male 1 1 1 1
Female 1?06 (0?96^1?18) 1?30** (1?18^1?45) 1?35*** (1?23^1?50) 0?99 (0?86^1?19)
Familyhistory No 1 1 1 1
Yes 2?76*** (2?14^3?42) 3?52*** (2?89^4?30) 3?45*** (2?80^4?21) 4?29*** (3?03^6?19)
Smokinghabits Non-smoker 1 1 1 1
Ex-smoker 1?0 (0?62^1?40) 1?30** (1?04^1?41) 1?39** (1?11^1?81) 1?31 (0?97^1?82)
Smoker55 cigarettes day71 1?57*** (1?20^2?13) 1?97*** (1?41^2?87) 1?45*** (1?13^1?98) 1?01 (0?59^1?66)
Smoker 5^14 cigarettes day71 2?47*** (1?79^3?56) 3?56*** (2?48^5?26) 2?09*** (1?48^3?07) 0?78 (0?55^1?10)
Smoker15 cigarettes day71 3?55*** (2?41^5?29) 5?06*** (3?61^7?14) 2?76*** (1?71^4?25) 0?85 (0?51^1?21)
Area of domicile Saaremaa 1 1 1 1
Tallinn 1?63*** (1?21^2?18) 1?39*** (1?19^1?83) 1?09 (0?97^1?26) 1?47** (1?09^2?05)
Narva 2?86*** (2?23^3?79) 2?88*** (2?33^3?58) 1?32*** (1?08^1?70) 1?42* (1?02^0?03)
*P50?05, **P50?01, ***P50?001.
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FIG. 3. Prevalence (%) of respiratory symptoms by smoking
habits.
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multiple logistic regression analysis (Table 5). The inde-
pendentvariablesused in themodelwere age, sex, family
history of obstructive airway disease (asthma or chronic
bronchitis/emphysema), smokinghabits and area of dom-
icile.
The risk for chronic productive cough increased
nearly linearly with the number of smoked cigarettes.
Smokers smoking4 15 cigarettes per day compared to
non-smokers had anORof 3?5.The other signi¢cant risk
factors for chronic productive coughwere increasing age
and a family history of obstructive airway disease, OR
2?8, while gender had no in£uence. A similar risk factor
pattern, but less pronounced with lower odds ratios,
was seen also for physician-diagnosed chronic bronchitis.
Family history was an even stronger risk factor for
physician-diagnosed chronic bronchitis than the
symptom chronic productive cough.
The risks for recurrent wheeze and for attacks of
shortness of breath were partly similar, however, the
risks for recurrent wheeze were also similar to those
for chronic productive cough. Recurrent wheeze was
even more smoking dependent than chronic productive
cough, but not asmuch dependentof increasing age than
chronic productive cough. The main risk factor for
asthmawas family history of asthma,OR 4?3.
Living in Narva compared with living in Saaremaa
was associated with an increased risk for most of the
above-mentioned conditions, yielding odds ratios from
OR 1?3 (attacks of shortness of breath) to 2?9 (both
chronic productive cough and recurrent wheeze). The
odds ratios for living in Tallinn compared with living in
Saaremaa were 1?6 for chronic productive cough, 1?4
for recurrent wheeze and l?5 for physician-diagnosed
asthma.
Analyses were performed by multiple logistic regres-
sion in order to examine weather or not interaction
existed between to two important risk factors, area ofdomicile and smoking. Amultiplicative e¡ect for the risk
of having recurrent wheeze, or chronic productive
cough, respectively, between area of domicile and smok-
inghabits.Thus theOR for recurrentwheeze for current
smokers living in Narva vs. non-smokers living in Saare-
maa was of 9?9 and the comparison between corre-
sponding citizens inTallinn vs. Saaremaa was 4?7.The OR
for current smokers vs. non-smokers in the pooled data
from all three areas was 3?4.
When performing the analyses for having chronic
productive cough, similar but slightly lower odds ratios
were found. The corresponding ¢gures for smokers in
Narva and smokers inTallinn, respectively, vs. non-smo-
kers in Saaremaa were OR 7?4 and 4?3, respectively,
while the OR for current smokers vs. non-smokers in
the pooled data from all three areas was 2?8. Interac-
tions of greatermagnitude than additive ormultiplicative
e¡ects were not found.
DISCUSSION
The study was the ¢rst large-scale study about respira-
tory symptoms and diseases performed in Estonia after
the restitution of the independence in1991.The European
Community Respiratory Health Survey (ECRHS)
performed in the city of Tartu in 1994 (7) studied the
prevalence of asthma related respiratory symptoms,
type l allergy, and hyper-reactivity among adults aged
20^44 years. Our study aimed to estimate the
prevalence not only of asthma, but also of chronic
bronchitis and respiratory symptoms in three di¡erent
geographic areas of Estonia including subjects aged up
to 64 years.
The selection of the areas aimed to give a cross-sec-
tional picture of Estonia including the rural area of the
island Saaremaa, the capital Tallinn, and the heavily in-
dustrialized town Narva. The ethnical composition of
the population necessitated the use of questionnaires
both in the Estonian and the Russian languages. As far
as we know the use of questionnaires in di¡erent lan-
guages created no adverse problems. Analyses of di¡er-
ences in symptoms, smoking habits, as well as of cultural
aspects between Estonians and Russians are in progress,
and a separate paper about this topic is planned.
The response rate to the postal questionnaire was
78%. It was similar or slightly lower compared with
recent studies in the Nordic countries (11^13,21) and the
local ECRHS (7), but higher or of similar range as the
ECRHS in France (22) and in other European countries.
The prevalence of male smokers, 57?2% was approxi-
mately twice as high as compared with the results from
recent studies from the Nordic countries (14,21,23^26).
Of the Estonianmen, 24% were heavy smokers consum-
ing 15 cigarettes or more per day. The prevalence of
female smokers was considerably lower and similar to
962 RESPIRATORYMEDICINElevels in the Nordic countries (13,14,23,26). The propor-
tion of current smokers decreased gradually after the
age of 40 years both among men and women.The same
trend has been observed in Sweden (11^13).
According to our study, the prevalence of physician-
diagnosed asthmawas only 2%,which is lower compared
to the prevalence found in studies in Nordic countries.
The most recent studies in the neighbouring countries
Sweden and Finland have shown the prevalence of physi-
cian-diagnosed asthma among adults to be 5^9%
(3,14,23^27). In contrast to the low prevalence of physi-
cian-diagnosed asthma, the prevalence of symptoms
common in asthma, such as attacks of shortness of
breath, frequent wheeze, any wheeze during the last 12
months, and combination of such symptoms, were simi-
lar or evenhigher thanreported from studies in theNor-
dic countries (3,14,23^26), indicating that asthma could
be under-diagnosed in Estonia. It is also noteworthy that
theprevalence of asthmamedicineuserswas higher than
the prevalence of physician-diagnosed asthma.
Nevertheless, the large di¡erences between Estonia
and neighbouring Nordic countries in prevalence on
disease level, and the more limited di¡erences on
symptom level, is probably the result of di¡erences in
diagnostic labelling of disease.Until the end of1980s, the
de¢nitions of chronic non-speci¢c respiratory diseases
o⁄cially accepted in the Soviet Unionwere used in Esto-
nia. Asthma was de¢ned as an allergic disease including
as essential symptoms: bronchospasm, dyspnoea,
hypersecretion and swelling of bronchial mucosa (28).
According to the Soviet Union era, asthma was de¢ned
as an allergic disease (20,21) either as an atopic disease
or due to ‘infection allergy’ (28^30). Other types of
variable broncho-obstruction, according to this de¢ni-
tion, should not be classi¢ed as asthma.Further, asthma
was often considered as a complication of, or a sub-
group to chronic bronchitis, or even to ‘chronic pneumo-
nia’ (29,30). It is noteworthy that asthma patients in the
Soviet Union were generally not allowed to travel
abroad, so physiciansmight hesitate to make the diagno-
sis of asthma.These facts support our opinion that asth-
ma, according to current criteria, has been under-
diagnosed.
Chronic bronchitis was during the Soviet era de¢ned
as a di¡use, usually progressive damage of the bronchial
tree caused by long-standing irritation of airways due to
di¡erent exposures, characterized by changes in secre-
tory system of themucosa, developmentof an in£amma-
tory process and of sclerotic changes on deeper levels of
the bronchial wall, accompanied by hypersecretion of
mucus, disturbance of bronchial clearance, factors which
allmaybe expressedclinically as permanentor recurrent
cough with sputum, and in case of damage of small
bronchi and bronchioli accompanied with dyspnoea.The
symptoms should not have been caused by the other
diseases (29, 30).When comparing our ¢ndings with the results of
studies performedup to 30 years ago in the Baltic States,
the prevalence of chronic bronchitis has not markedly
changed (8). The prevalence of diagnosed chronic bron-
chitis in Estonia is nearly twice as high as in Scandinavian
countries (11^13), but similar to that in the United King-
dom,where chronic bronchitiswas found to a¡ect17%of
men and 7% of women (31). Despite the higher preva-
lence of smokers among men than women in our study,
the prevalence of chronic bronchitis was found to be
higher in women. Further, in all di¡erent smoking
categories, and in all study areas, physician-diagnosed
chronic bronchitis was more common among women.
The notably high prevalence of cough, sputum produc-
tion and chronic bronchitis in non-smoking women in
Estonia, but not of asthma, is an important ¢nding and
point out the need of further studies of the topic. The
¢nding may in part be due to the local classi¢cation of
disease, and a hypothesis is that many of these women
may have asthma.
Exposure from environmental tobacco smoke (ETS)
may contribute to these high prevalence rates among
non-smokers, in particular non-smoking women. In
Estonia, compared to the Nordic countries, many
families have small apartments and live in overcrowded
conditions (33).Thismeans that if, for example, the father
in a family smokes, the other non-smoking family mem-
bers are at risk for considerable ETS exposure. The
e¡ects of ETS in women may be more serious than in
men, since women may be more susceptible tobacco
smoke (34).
In contrast to other studies in Europe (9^14,21,23,31),
the prevalence of chronic productive cough was lower
than theprevalence ofphysician-diagnosed chronic bron-
chitis, which became apparent especially among non-
smokers, a ¢nding that may be a result of di¡erent diag-
nostic labelling in£uenced by the criteria used in former
Soviet Union (29).There was no minimum time limit for
the symptomatic period, e.g. 3 months a year during at
least 2 successive years (35), to make the diagnosis of
chronic bronchitis according to the Soviet de¢nition of
chronic bronchitis.
The prevalence of at least one respiratory symptom
was 45% among the Estonian adults, results similar or
only slightly higher than found in Norway and Sweden
(11^13,2l). Generally, the risk for respiratory symptoms
increased with increasing number of smoked cigarettes.
Of therisk factors, also obstructive airwaydisease in the
family was signi¢cantly related with every symptom or
condition, and was the greatest risk factor found for
asthma, OR 4, results in accordance with others (3,24).
Female sex was a risk factor for symptoms common in
asthma, however, for diagnosed asthma no gender di¡er-
ences were found.
Living in the polluted area of Narva was associated
with the highest risk for mainly bronchitic symptoms,
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age, gender, and family history of obstructive airway dis-
eases. In addition to general air pollution, the industrial
setting of the Narva regionmay also contribute to occu-
pational airborne exposure of importance. Living in the
rural Saaremaa was associated with the lowest risk for
all symptoms and conditions. Multiplicative e¡ects was
found for havingrecurrentwheeze or chronicproductive
cough between smoking habits and area of domicile. For
smokers living in Narva vs. non-smokers living in Saare-
maa the ORs were 8^10 for having either one or the
other of these two conditions. In agreementwith others
(33,36), an urban factor was also found for asthma and
living in Tallinn or Narva, compared with Saaremaa
yielded an increased risk of being diagnosed as having
asthma or symptoms common in asthma.
In conclusion, we found a large proportion of smokers
among Estonian men, and the prevalence of most
respiratory symptoms were similar or higher than in
the Nordic countries by using the same questionnaire
which has been used in several studies in the Nordic
countries. Despite a high prevalence of symptoms com-
mon in asthma, the prevalence of physician-diagnosed
asthma was low indicating an underdiagnosis of asthma
in Estonia probably due to diagnostic traditions based
on the Soviet-time de¢nitions of asthma.Highprevalence
of respiratory symptoms may be due not only to
smoking, but probably also to exposure to ETS in
overcrowded Estonian homes.This important indication
of the deleterious e¡ect of indoor climate, especially in-
tensive exposure to ETS, needs further studies.
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